Veredus Laboratories
Singapore, Singapore· Est.
A Singapore‑based IVD developer delivering rapid PCR and point‑of‑care tests for infectious disease and biosurveillance.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
A Singapore‑based IVD developer delivering rapid PCR and point‑of‑care tests for infectious disease and biosurveillance.
Infectious DiseaseFood SafetyBiosurveillanceClinical ChemistryDiabetesCoagulationWomen's HealthGastrointestinal
Technology Platform
Proprietary PCR and Lab‑on‑Chip microfluidic platforms combined with OSOM® rapid‑test lateral‑flow technology for point‑of‑care and high‑throughput diagnostics.
Opportunities
Expansion into US and European markets, leveraging pending FDA approvals, and growing demand for rapid multiplex diagnostics for pandemic preparedness and food‑safety surveillance.
Risk Factors
Regulatory hurdles in major markets, intense competition from larger IVD manufacturers, and potential supply‑chain constraints for reagents and components.
Competitive Landscape
Competes with global IVD leaders such as Abbott, Roche, and Quidel, but differentiates through its Lab‑on‑Chip microfluidic expertise and specialized biosurveillance solutions.